Upgrade to SI Premium - Free Trial

FRNM (FRNM)

14.02 -0.04 (0.28%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/10/26)

Latest Headlines

Form 424B3 Freenome, Inc. October 20, 2026 9:26 AM - SEC Filing Form 8-K Freenome, Inc. For: Oct 20 October 20, 2026 8:53 AM - SEC Filing Freenome Expands Personalized Cancer Detection Portfolio, Launching SimpleScreen™ Lung Test With FDA-Approved SimpleScreen CRC Option October 20, 2026 8:30 AM - StreetInsider Freenome to Report Third Quarter 2026 Financial Results on November 10, 2026 October 15, 2026 4:29 PM - Globe NewsWire Freenome to Present New Validation Data for Next-Generation CRC Screening Test in Late-Breaking Oral Presentation at ACG 2026 October 11, 2026 1:00 PM - StreetInsider Form S-8 Freenome, Inc. September 23, 2026 5:06 PM - SEC Filing Form EFFECT Freenome, Inc. August 28, 2026 6:08 AM - SEC Filing Form 424B3 Freenome, Inc. August 27, 2026 4:30 PM - SEC Filing Guggenheim Starts Freenome Inc. (FRNM) at Buy August 20, 2026 6:19 AM - StreetInsider Form S-1 Freenome, Inc. August 18, 2026 4:52 PM - SEC Filing TD Cowen Starts Freenome Inc. (FRNM) at Buy August 18, 2026 5:33 AM - StreetInsider BTIG Starts Freenome Inc. (FRNM) at Buy August 17, 2026 5:31 AM - StreetInsider Jefferies Starts Freenome Inc. (FRNM) at Buy August 17, 2026 2:30 AM - StreetInsider Form SCHEDULE 13G/A Freenome, Inc. Filed by: ADAR1 Capital Management, LLC August 14, 2026 5:00 PM - SEC Filing Form SCHEDULE 13G Freenome, Inc. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC August 14, 2026 12:36 PM - SEC Filing Leerink Starts Freenome Inc. (FRNM) at Outperform August 14, 2026 6:12 AM - StreetInsider Form 8-K/A Freenome, Inc. For: Jul 20 August 13, 2026 5:29 PM - SEC Filing Form SCHEDULE 13G/A Freenome, Inc. Filed by: IPConcept (Luxemburg) S.A. August 12, 2026 5:34 PM - SEC Filing Form SCHEDULE 13G/A Freenome, Inc. Filed by: 683 Capital Management, LLC August 12, 2026 11:13 AM - SEC Filing FDA grants breakthrough device status to Freenome's lung cancer blood test August 12, 2026 9:00 AM - StreetInsider FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based SimpleScreen™ Lung Cancer Screening Test August 12, 2026 9:00 AM - StreetInsider Form SCHEDULE 13G/A Freenome, Inc. Filed by: BIT Capital GmbH August 5, 2026 6:27 AM - SEC Filing Form 4 Freenome, Inc. For: Jul 20 Filed by: Waksal Harlan July 29, 2026 5:19 PM - SEC Filing Form 3 Freenome, Inc. For: Jul 20 Filed by: Elliott Aaron Matthew July 27, 2026 8:48 PM - SEC Filing Form 3 Freenome, Inc. For: Jul 20 Filed by: Nuechterlein Carole July 27, 2026 8:48 PM - SEC Filing Form 3 Freenome, Inc. For: Jul 20 Filed by: Scott Randal W. July 27, 2026 8:48 PM - SEC Filing Form 3 Freenome, Inc. For: Jul 20 Filed by: Lin Cheng-Ho Jimmy July 27, 2026 8:48 PM - SEC Filing Form 3 Freenome, Inc. For: Jul 20 Filed by: Ennis Riley Charles July 27, 2026 8:48 PM - SEC Filing Form 3 Freenome, Inc. For: Jul 20 Filed by: PAKIANATHAN DEEPIKA July 27, 2026 8:48 PM - SEC Filing Form 3 Freenome, Inc. For: Jul 20 Filed by: Costello Ann Catherine July 27, 2026 8:48 PM - SEC Filing Form 3 Freenome, Inc. For: Jul 20 Filed by: Le Linh H. July 27, 2026 8:48 PM - SEC Filing Form 3 Freenome, Inc. For: Jul 20 Filed by: VAN OORT DOUGLAS M July 27, 2026 8:48 PM - SEC Filing FDA approves Freenome's blood-based colorectal cancer screening test July 27, 2026 8:00 AM - StreetInsider FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S. July 27, 2026 8:00 AM - StreetInsider Form 4 Freenome, Inc. For: Jul 20 Filed by: SONG KENNETH July 24, 2026 4:08 PM - SEC Filing Form 4 Freenome, Inc. For: Jul 20 Filed by: Perceptive Capital Solutions Holdings July 23, 2026 4:49 PM - SEC Filing Full Article List